Back to results
US 2012/0238835 A1Published application
System, devices, and methods for real-time monitoring of cerebrospinal fluid for markers of progressive conditions
AssigneeSearete LLC, a limited liability corporation of the State of Delaware
InventorsRoderick A. Hyde, Sharon L. Wolda, Lowell L. Wood, JR.
Life of this patent
Estimating the term…
Abstract
Systems, devices, methods, and compositions are described for providing real-time monitoring of cerebrospinal fluid for markers of progressive conditions.
Claims28
-353. (canceled)
An implantable wireless biotelemetry device, comprising:
- a sensor component configured to detect at least one biomarker profile of a cerebrospinal fluid received within one or more fluid-flow passageways of the implantable wireless biotelemetry device;
- one or more computer-readable memory media including executable instructions stored thereon that, when executed on a computer, instruct a computing device to
- retrieve from storage one or more parameters associated with reference cerebrospinal fluid biomarker spectral information associated with at least one neuropsychiatric disorder, and to
- perform a comparison of a detected at least one biomarker profile to the retrieved one or more parameters;
- and
- a transceiver operable to concurrently or sequentially transmit or receive information in response to the comparison.
3 more elements
(canceled)
(canceled)
(canceled)
A method, comprising:
- comparing an in vivo real-time detected measurand of cerebrospinal fluid from an indwelling implant to biological subject specific mental disorder filtering information configured as a physical data structure and stored in one or more non-transitory computer-readable memory media;
- and
- generating a response based at least in part on the generated one or more comparisons.
(canceled)
(canceled)
An in vivo method for real-time monitoring of one or more biomarkers within a cerebrospinal fluid, comprising:
- performing an in vivo comparison of a detected change in a spectral absorption profile of one or more biomarkers present in a cerebrospinal fluid received with an implanted shunt to neuropsychiatric disorder information;
- and
- transcutaneously transmitting a response based on the comparison of the detected energy spectral profile to the characteristic spectral signature information.
(canceled)
A monitoring method, comprising:
- generating one or more comparisons between at least one in vivo real-time detected measurand from an indwelling implant and biological subject specific mental disorder filtering information configured as a physical data structure and stored in one or more non-transitory computer-readable memory media carried by the indwelling implant;
- and
- generating a response based at least in part on the generated one or more comparisons.
(canceled)
-391. (canceled)
Dependencies are inferred from the claim text.